Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference - Arcutis Biotherapeutics ( NASDAQ:ARQT )
WESTLAKE VILLAGE, Calif., Aug. 22, 2024 ( GLOBE NEWSWIRE ) -- Arcutis Biotherapeutics, Inc. ARQT, a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will participate in the Morgan Stanley 22nd ...
| Ticker |
Sentiment |
Impact |
|
META
|
Somewhat Bullish
|
13 %
|
|
ARQT
|
Bullish
|
50 %
|
|
MS
|
Neutral
|
13 %
|
